Regulation of autologous immunity to the mouse 5T4 oncofoetal antigen: implications for immunotherapy. (Q45025116)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22127365%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Regulation of autologous immunity to the mouse 5T4 oncofoetal antigen: implications for immunotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22127365%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22127365%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Peter Stern

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22127365%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Fernanda V Castro

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22127365%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Mariam Al-Muftah

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22127365%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Kate Mulryan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22127365%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Hui-Rong Jiang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22127365%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Jan-Wouter Drijfhout

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22127365%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Sumia Ali

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22127365%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Andrzej J Rutkowski

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22127365%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Milena Kalaitsidou

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22127365%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

30 November 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22127365%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22127365%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22127365%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22127365%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

1005-1018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22127365%20AND%20SRC:MED&resulttype=core&format=json

Cancer immunotherapy: moving beyond current vaccines

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1167-3

Immune therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1167-3

A 72 kD trophoblast glycoprotein defined by a monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1167-3

Isolation and characterization of 5T4, a tumour-associated antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1167-3

Immunohistological distribution of 5T4 antigen in normal and malignant tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1167-3

Prognostic significance of 5T4 oncofetal antigen expression in colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1167-3

5T4 interacts with TIP-2/GIPC, a PDZ protein, with implications for metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1167-3

Metastasis-associated 5T4 antigen disrupts cell-cell contacts and induces cellular motility in epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1167-3

CXCR4 mediated chemotaxis is regulated by 5T4 oncofetal glycoprotein in mouse embryonic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1167-3

A phase II study of a 5T4 oncofoetal antigen tumour-targeted superantigen (ABR-214936) therapy in patients with advanced renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1167-3

Expression of the 5T4 oncofoetal antigen in renal cell carcinoma: a potential target for T-cell-based immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1167-3

Cross-trial analysis of immunologic and clinical data resulting from phase I and II trials of MVA-5T4 (TroVax) in colorectal, renal, and prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1167-3

Vaccination of Metastatic Renal Cancer Patients with MVA-5T4: A Randomized, Double-Blind, Placebo-Controlled Phase III Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1167-3

MVA-5T4-induced immune responses are an early marker of efficacy in renal cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1167-3

Danger signals and nonself entity of tumor antigen are both required for eliciting effective immune responses against HER-2/neu positive mammary carcinoma: implications for vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1167-3

An MVA vaccine overcomes tolerance to human p53 in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1167-3

Modified vaccinia Ankara expressing survivin combined with gemcitabine generates specific antitumor effects in a murine pancreatic carcinoma model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1167-3

Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1167-3

Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1167-3

IL-6: regulator of Treg/Th17 balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1167-3

Multiple antitumor mechanisms downstream of prophylactic regulatory T-cell depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1167-3

Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1167-3

E-cadherin inhibits cell surface localization of the pro-migratory 5T4 oncofetal antigen in mouse embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1167-3

Characterization of the murine 5T4 oncofoetal antigen: a target for immunotherapy in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1167-3

Embryonic expression of murine 5T4 oncofoetal antigen is associated with morphogenetic events at implantation and in developing epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1167-3

Tumor-specific Th17-polarized cells eradicate large established melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1167-3

Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1167-3

High-avidity autoreactive CD4+ T cells induce host CTL, overcome T(regs) and mediate tumor destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1167-3

How specificity for self-peptides shapes the development and function of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1167-3

CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1167-3

Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1167-3

Multiple roles for CD4+ T cells in anti-tumor immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1167-3

T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1167-3

Reprogrammed foxp3(+) regulatory T cells provide essential help to support cross-presentation and CD8(+) T cell priming in naive mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1167-3

Adoptive transfer of tumor-specific Tc17 effector T cells controls the growth of B16 melanoma in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1167-3

Cutting edge: Phenotypic characterization and differentiation of human CD8+ T cells producing IL-17.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1167-3

Tc17 CD8 T cells: functional plasticity and subset diversity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1167-3

Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1167-3

10.1007/S00262-011-1167-3

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22127365%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

17 January 2020

1012192706

0 references

1 reference